# Filing Detail

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-17-065382
Filing Date
2017-11-02
Accepted
2017-11-02 07:34:35
Documents
25
Period of Report
2017-11-02

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 6-K | a17-24928_16k.htm | 6-K | 78174
2 | GRAPHIC | g249281bci001.gif | GRAPHIC | 94412
3 | GRAPHIC | g249281bci002.gif | GRAPHIC | 110946
4 | GRAPHIC | g249281bci003.gif | GRAPHIC | 72006
5 | GRAPHIC | g249281bci004.gif | GRAPHIC | 109358
6 | GRAPHIC | g249281bci005.gif | GRAPHIC | 97236
7 | GRAPHIC | g249281bci006.gif | GRAPHIC | 99862
8 | GRAPHIC | g249281bci007.gif | GRAPHIC | 92877
9 | GRAPHIC | g249281bci008.gif | GRAPHIC | 104991
10 | GRAPHIC | g249281bci009.gif | GRAPHIC | 105374
11 | GRAPHIC | g249281bei001.gif | GRAPHIC | 15745
12 | GRAPHIC | g249281bei002.gif | GRAPHIC | 91110
13 | GRAPHIC | g249281bei003.gif | GRAPHIC | 52057
14 | GRAPHIC | g249281bei004.gif | GRAPHIC | 41194
15 | GRAPHIC | g249281bei005.gif | GRAPHIC | 59299
16 | GRAPHIC | g249281bei006.gif | GRAPHIC | 51887
17 | GRAPHIC | g249281bei007.gif | GRAPHIC | 40750
18 | GRAPHIC | g249281bei008.gif | GRAPHIC | 65948
19 | GRAPHIC | g249281bei009.gif | GRAPHIC | 65567
20 | GRAPHIC | g249281bei010.gif | GRAPHIC | 65090
21 | GRAPHIC | g249281bei011.gif | GRAPHIC | 69395
22 | GRAPHIC | g249281bei012.gif | GRAPHIC | 46060
23 | GRAPHIC | g249281bei013.gif | GRAPHIC | 51809
24 | GRAPHIC | g249281bei014.gif | GRAPHIC | 39641
25 | GRAPHIC | g249281bei015.gif | GRAPHIC | 41625
| Complete submission text file | 0001104659-17-065382.txt |  | 2401139

Mailing Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036
Business Address 1585 BROADWAY SUITE 2376 NEW YORK NY 10036 212-969-3335
Grifols SA (Filer) CIK: 0001438569 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-35193 | Film No.: 171170744
SIC: 2834 Pharmaceutical Preparations